Abstract
A dihydroquinolinone moiety was found to be a potent serotonin reuptake inhibitor pharmacophore when combined with certain amines. This fragment was coupled with selected D2 ligands to prepare a series of dual acting compounds with attractive in vitro profiles as dopamine D2 partial agonists and serotonin reuptake inhibitors. Structure-activity studies revealed that the linker plays a key role in contributing to D2 affinity, function, and SRI activity.
Original language | English |
---|---|
Pages (from-to) | 2983-2986 |
Number of pages | 4 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 20 |
Issue number | 9 |
DOIs | |
State | Published - 1 May 2010 |
Keywords
- Dopamine D partial agonist
- Schizophrenia
- Serotonin reuptake inhibitor